Author:
Yamamoto Masayo,Tanaka Hiroki,Toki Yasumichi,Hatayama Mayumi,Ito Satoshi,Addo Lynda,Shindo Motohiro,Sasaki Katsunori,Ikuta Katsuya,Ohtake Takaaki,Fujiya Mikihiro,Torimoto Yoshihiro,Kohgo Yutaka
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. List AF, Sandberg AA, Doll DC. Myelodysplastic Syndromes. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B, editors. Wintrobe’s clinical hematology. 11th ed. Philadlphia: Lippincott Williams & Wilkins; 2004. p. 2207–34.
2. Shlush LI, Zandi S, Itzkovitz S, Schuh AC. Aging, clonal hematopoiesis and preleukemia: not just bad luck? Int J Hematol. 2015;102:513–22.
3. Takatoku M, Uchiyama T, Okamoto S, Kanakura Y, Sawada K, Tomonaga M, et al. Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality. Eur J Haematol. 2007;78:487–94.
4. Neukirchen J, Fox F, Kündgen A, Nachtkamp K, Strupp C, Haas R, et al. Improved survival in MDS patients receiving iron chelation therapy—a matched pair analysis of 188 patients from the Düsseldorf MDS registry. Leuk Res. 2012;36:1067–70.
5. Rose C, Brechignac S, Vassilief D, Pascal L, Stamatoullas A, Guerci A, et al. GFM (Groupe Francophone des Myélodysplasies). Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM (Groupe Francophone des Myélodysplasies). Leuk Res. 2010;34:864–70.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献